Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

JG Gaultney, Rob de Knegt, P Fassler, S Visser, S Johnson

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Article numberA588
JournalValue in Health
Volume18
Issue number7
Publication statusPublished - 2015

Research programs

  • EMC MM-04-20-02-A

Cite this